The total amount of the transaction was worth $64,500, noted the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
Boston Scientific is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties, including interventional cardiology, endoscopy, peripheral interventions and urology/women’s health, according to the report.
More articles on GI/endoscopy:
Global endoscopy market to reach $47B by 2020: 8 key trends
GI Dynamics names Michael Dale president & CEO
Diagnostic Endoscopy Center’s Dr. Stuart Waldstreicher honored
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.